Live Breaking News & Updates on எண்டோமெட்ரியோசிஸ்|Page 4

Stay updated with breaking news from எண்டோமெட்ரியோசிஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reinventing the Uterus, One Organoid at a Time


as well as trans men
and nonbinary people
The Great ReadProfiles In Science
Reinventing the Uterus, One Organoid at a Time
Bioengineer Linda Griffith once grew a human ear on the back of a mouse. Now she is reframing endometriosis a “women’s disease” as a key to unlocking some of biology’s greatest secrets.
Linda G. Griffith is a professor of biological and mechanical engineering at M.I.T., and its director of the Center for Gynepathology Research. “I don’t want to make endometriosis a women’s issue,” she said in 2014. “I want to make it an M.I.T. issue.” ....

United Kingdom , Linda Griffith , Gynepathology Research , M It Center , Your Feed Science , Your Feed Health , Human Tissue , Gynecology And Gynecologists , Breast Cancer , Biotech Bioengineering , ஒன்றுபட்டது கிஂக்டம் , லிண்டா கிரிஃபித் , மீ அது மையம் , உங்கள் தீவனம் அறிவியல் , உங்கள் தீவனம் ஆரோக்கியம் , மனிதன் திசு , பெண்ணோயியல் மற்றும் மகப்பேறு மருத்துவர்கள் , மார்பக புற்றுநோய் , பயோடெக் உயிர் பொறியியல் ,

Health minister announces 'see-and-treat' gynaecology services and 'advanced' endometriosis centre


Health minister announces see-and-treat gynaecology services and advanced endometriosis centre
These two health policies are recommendations from the Women’s Health Taskforce, established by the Department of Health in September 2019.
By Gráinne Ní Aodha
Wednesday 21 Apr 2021, 10:34 PM
4 hours ago
9,250 Views
11 Comments
Image: Shutterstock/New Africa
Image: Shutterstock/New Africa
THE MINISTER FOR Health Stephen Donnelly has announced new funding for two “key” women’s health projects – including a €641,000 investment in an endometriosis service in Dublin to focus on more complex cases.
The first is the provision of two community-based ambulatory gynaecology services, governed by two acute hospitals – Tallaght University Hospital, and University Maternity Hospital Limer ....

North Tipperary , County South Dublin , University Maternity Hospital Limerick , Health Stephen Donnelly , Department Of Health , Women Health Taskforce , Tallaght University Hospital , Stephen Donnelly , Nenagh General , Health Task Force , Support The , Minister For Health , Stephen Donnelly , Womens Health , Womens Healthcare , வடக்கு உதவிக்குறிப்பு , கவுண்டி தெற்கு டப்ளின் , பல்கலைக்கழகம் மகப்பேறு மருத்துவமனை லிமரிக் , ஆரோக்கியம் ஸ்டீபன் டோநிலீ , துறை ஆஃப் ஆரோக்கியம் , ஸ்டீபன் டோநிலீ , ஆரோக்கியம் பணி படை , ஆதரவு தி ,

What is endometriosis and how can it affect fertility?


facebook
Pintrest
The term endometriosis comes from the word endometrium , which is the uterine lining developed by your body each month in preparation for egg implantation. If a woman does not conceive within a month, the body sheds the endometrium and one gets their periods. The endometrial tissue passes through the fallopian tube and into the abdomen.
The tissue sometimes can bind to the other organs in some women. When the hormones are released during the next menstrual cycle, it causes the extra tissue to develop and then shed, much like the tissue in the uterus.
The bleeding and tissue shedding has no means of leaving the body, causing inflammation of local tissue. The discomfort felt by patients with endometriosis is often caused by inflammation. ....

What Is Endometriosis ,

Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily


Date Time
Share
Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily
SERENE is a Phase 3 single-arm, open-label study evaluating the contraceptive efficacy of investigational relugolix combination tablet in sexually active, healthy women ages 18-35 years
Contraceptive potential of relugolix combination tablet supported by prior Phase 1 study that demonstrated 100% ovulation inhibition
Data would support a potential indication of pregnancy prevention for women treated with relugolix combination tablet, if approved
BASEL, Switzerland and NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 SERENE study evaluating the contraceptive efficacy of relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) in healthy women age ....

James Rusnak , Juan Camilo Arjona Ferreira , Pfizer Inc , Myovant Sciences Inc , Myovant Sciences , Drug Administration , Global Product Development At Pfizer , Chief Medical Officer , Pearl Index , Senior Vice President , Chief Development Officer , Internal Medicine , Global Product Development , New Drug Application , Health Care , ஜேம்ஸ் ருஸ்னக் , ஃபைசர் இன்க் , உலகளாவிய ப்ராடக்ட் வளர்ச்சி இல் ஃபைசர் , தலைமை மருத்துவ அதிகாரி , முத்து குறியீட்டு , மூத்தவர் துணை ப்ரெஸிடெஂட் , தலைமை வளர்ச்சி அதிகாரி , உள் மருந்து , உலகளாவிய ப்ராடக்ட் வளர்ச்சி , புதியது மருந்து விண்ணப்பம் , ஆரோக்கியம் பராமரிப்பு ,